Navigation Links
SI-BONE, Inc. franchit le cap des 10 000 interventions chirurgicales
Date:1/6/2014

tefois, malgré cette réussite considérable, nous savons qu'il existe encore un grand nombre de patients atteints de dégénérescence sacro-iliite ou de dislocations de l'articulation sacro-iliaque pour lesquels la thérapie traditionnelle a échoué, et nous continuerons nos efforts de sensibilisation auprès des patients, des professionnels de santé et des assureurs quant aux avantages d'iFuse en tant qu'option de traitement en faveur de ces patients, » a déclaré Jeffrey Dunn, président et PDG de SI-BONE.

Steven Garfin, docteur en médecine, professeur émérite et président du Département de chirurgie orthopédique de l'UC de San Diego, a déclaré : « Il y a un peu plus de quatre ans, j'ai été intrigué lorsque j'ai découvert pour la première fois SI-BONE et la procédure iFuse, et j'ai pensé qu'il s'agissait d'une avancée utile destinée seulement à un nombre très limité de patients. Pourtant aujourd'hui, un peu plus de quatre ans après et à l'issue de plus de 10 000 interventions, il est clair que les troubles de l'articulation SI qu'il est possible de traiter avec iFuse sont bien plus répandus que ce que nous le pensions autrefois. La société SI-BONE est à l'origine de cette nouvelle approche en faveur du traitement de l'articulation SI, et l'iFuse constitue l'unique dispositif CMI ayant publié des preuves cliniques appuyant sa sécurité et son efficacité d'utilisation. Je suis impressionné par les efforts fournis par la Société en faveur des patients. »

SI-BONE, Inc. a initialement obtenu une approbation 510(k) en novembre 2008 de la part de la Food and Drug Administration (FDA) pour la commercialisation de s
'/>"/>

SOURCE SI-BONE, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. SI-BONE, Inc. Announces Spring Society Meeting Attendance
2. SI-BONE, Inc. Announces Publication of Postmarket Surveillance Safety Data on First 5,319 Patients Treated with iFuse Implant System
3. SI-BONE, Inc. annuncia la pubblicazione dei dati sulla sicurezza della sorveglianza post-commercializzazione per i primi 5.319 pazienti trattati con il sistema di impianto iFuse Implant System
4. SI-BONE, Inc. Announces 25,000 iFuse Implant Milestone
5. SI-BONE, Inc. annuncia il raggiungimento di 25.000 impianti iFuse
6. MRI Interventions Named 2012 Global Company of the Year in Image-Guided Neural Interventions
7. MRI Interventions CEO to Present at 2013 Brain Tumor Biotech Summit regarding MRI-Guided Therapies for Brain Cancer
8. Micell Technologies Announces DESSOLVE I Manuscript Accepted for Publication in American College of Cardiologys Cardiovascular Interventions Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015 Hologic, Inc. ... plans to release its financial results for the third ... after the market closes.  In conjunction with the release, ... 4:30 p.m. Eastern Time. Interested participants may ... the United States ) or 719-325-4804 (for ...
(Date:7/6/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/58tdl6/pharmaceutical ) ... Sodium Chloride Market by Applications, by Region - Industry ... offering. The pharmaceutical grade sodium chloride market ... 2014 and 2019 in terms of volume, and the ... The report on Pharmaceutical grade sodium chloride ...
(Date:7/6/2015)... July 6, 2015 Array BioPharma,s (NASDAQ: ... this past weekend at the 2015 ESMO World ... At the meeting, data were shared from a ... 100-patient randomized Phase 2 expansion of that trial ... EGFR inhibitor, with or without the addition of ...
Breaking Medicine Technology:Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4
... , ORLANDO, Fla. , May 19 ... of medicine to their daily routine.  In 2009, drug trend ... increased 10.8 percent, driven by a 5 percent increase in ... 2010 Drug Trend Report.  The growth in prescription drug use ...
... May 19 Five presentations reporting the ... LYSTEDA™ (tranexamic acid) tablets, a novel, first-in-class, non-hormonal therapy ... bleeding (HMB), were presented at The American College of ... San Francisco , May 15-19, 2010 .  It ...
Cached Medicine Technology:New Research: Kids' Consumption of Chronic Medications on the Rise 2New Research: Kids' Consumption of Chronic Medications on the Rise 3New Research: Kids' Consumption of Chronic Medications on the Rise 4New Research: Kids' Consumption of Chronic Medications on the Rise 5Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 2Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 3Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 4Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 5Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 6
(Date:7/6/2015)... ... 06, 2015 , ... Invitation to Cover: , Most African ... large gap between the unmet health priorities in the region and the kind ... unnecessary or ineffective treatments or procedures. , This milestone conference, sponsored by Columbia ...
(Date:7/6/2015)... ... July 06, 2015 , ... Olive Fertility Centre is ... 2014-2015 Post Graduate Teaching Award on behalf of the department of Family Practice. , ... exciting field to be practicing in. The technology is changing so rapidly and we ...
(Date:7/6/2015)... ... 2015 , ... Longevity, the highest regarded provider of early ... Care to offer on-site health screenings. These ultrasound screenings detect early signs of ... accurate and run about an hour long with same day results. , Early ...
(Date:7/6/2015)... ... July 06, 2015 , ... Health care systems and ... of the medical field to access and use this “Big Data” to improve health ... and Chief Executive Officer of the Mount Sinai Health System in New York City. ...
(Date:7/6/2015)... ... July 06, 2015 , ... In a split second, breaking a bone can ... of having a fracture through the bone health screenings conducted by American Bone Health ... participating because our residents need this information to remain independent and strong for many ...
Breaking Medicine News(10 mins):Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:National Bone Health Screening and Awareness Day 2
... monoxide emissions has resulted in a drop in poisoning ... is involved in a number of accidental deaths and ... are vehicle emissions and malfunctioning domestic heating equipment. In ... US to reduce carbon monoxide. The use of catalytic ...
... it may be possible to increase the supply of lungs ... Researchers in San Francisco and Nashville have been looking at ... 80 per cent of lungs are rejected. That's a very ... ,The researchers checked 30 pairs of lungs that ...
... researchers in England, a baby's birth weight is connected ... study also shows women with the lightest and heaviest ... ,More than 4,100 women ages between 62 and 75 ... weight increased every 2.2 lbs, women had a 12% ...
... Colulmbia University found that eating more calories and fats ... some people. Previous research has shown that mice and ... //Researchers feel this is because of fewer destructive molecules ... destructive molecules, known as free radicals also damage cells ...
... body. When sweet corn is heated, its antioxidant content is ... healthy addition to one's diet.// There has always been a ... their nutritional content. According to new study, one loses some ... well gain more antioxidant power than you lose on cooking. ...
... unnecessarily because they really don't have allergies," said Sheryl ... at Ohio State University. "They're often prescribed antihistamines that ... 246 patients showed researchers that nearly two out of ... percent of the patients tested negative for allergies; the ...
Cached Medicine News:Health News:Diet combined to Alzheimer's disease 2
... A necessary addition to ... the Reichert Trial Frame ... and smooth controls for ... robust design, high-quality materials, ...
... The Ultramatic Rx Master is ... years of reliable service and ... that measurably improve procedures. It ... need and want most, including ...
The Maverick Over-The-Wire balloon catheter delivers a new level of performance to meet the changing demands of interventional cardiology....
... Illumination is provided by a cool-running, energy ... only what you need to see without ... of all they are maintenance free so ... bulb. Every Phoroptor comes with a limited ...
Medicine Products: